8 Coupons
-
Special Offer
-
30% off
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims. .
"we were quite surprised to find there were no significant differences," says study author . .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .: "fremanezumab for the preventive treatment of chronic migraine." .
read more on
.